$Canaan (CAN.US)$ China Securities collectively took to the streets, and Alibaba all fell by 2/3. Under the guise of an audit, the US called for China to be delisted. The Chinese side defines Futu and Tiger's behavior as driving without a license in China. Seems like a very tacit agreement. It seems that the policies of both countries do not want China to continue to waver in the US. We can only privatize and delist one after another, and switch to the Hong Kong path? If they collectively fall below one dollar and get forced back, then that would be very embarrassing. The question is, can Hong Kong accept a multi-trillion metre Chinese market re-listing? It's strange that the Hang Seng Index doesn't fall. Obviously, the supply of stocks will exceed demand.
Translated
3
$Shenzhen Zqgame (300052.SZ)$ Metaverse concept stocks have continued to be popular recently, and many individual stocks have risen surprisingly in the short term. This has attracted great attention from the supervisory authorities. Following the receipt of a letter of concern from the exchange by China Qingbao, Shengtian Network, and Tianxia Xiu, yesterday evening, the metaverse concept upstart Yishang Display, which had been rising and falling for 4 consecutive times, also received a letter of concern from the Shenzhen Stock Exchange. Regarding the recent rise in the company's stock price, the letter of concern directly asked: Is it trending in the metaverse?
Although the metaverse concept has received continued attention from regulators, it has not been possible to quench investors' enthusiasm for hype. Overnight, Roblox, the first metaverse stock listed on the US NASDAQ, rose more than 40%, and its stock price hit a new high since listing, once again injecting momentum into the A-share metaverse concept hype. Yi Shang showed that it only slightly adjusted after opening low, then went up again. By the end of the afternoon session, it had a rise or fall.
The Metaverse Concept Index, which was just adjusted yesterday, once again jumped high today. The intraday volume bucked the trend and surged by more than 4%, reaching a record high. Half-day transactions surpassed yesterday's full-day transactions. Chinese Online and Liyuan Information went up and down 20%, while Phillips, Changxin Technology, etc. rose or dropped by more than 10%.
The hype about the metaverse concept is not only unaffected by regulation; on the contrary, there are signs of spread. Today, in response to an investor's question about “whether the company holds Uki shares in the social metaverse that targets Facebook,” Yongji Co., Ltd. replied on the Interactive Easy platform that currently the company's investment fund Jianzheng Yongji holds 6.8% of the shares in Shanghai Niuka Information Technology Co., Ltd. The company will promptly fulfill its credit disclosure obligations in accordance with relevant regulations in accordance with subsequent progress. Yongji shares had a sharp rise in early trading from near flat in just a few minutes.
Pingzhi Information announced today that in order to promote cooperation in VR related fields and promote the development of the VR industry, the company signed a “Strategic Cooperation Framework Agreement” with China Mobile (Jiangxi) Virtual Reality Technology Co., Ltd. and Dafeng Robotics Co., Ltd. on November 9, 2021 based on the principles of complementary advantages, equality and mutual benefit, and long-term cooperation, with the aim of jointly reaching strategic cooperation in the fields of VR/AR, robotic metaverse, artificial intelligence, and digital twins. The Pingji information rose and stopped a second after opening sharply higher in early trading. The transactions in the first minute of opening were higher than yesterday's full-day transactions.
Although the metaverse concept has received continued attention from regulators, it has not been possible to quench investors' enthusiasm for hype. Overnight, Roblox, the first metaverse stock listed on the US NASDAQ, rose more than 40%, and its stock price hit a new high since listing, once again injecting momentum into the A-share metaverse concept hype. Yi Shang showed that it only slightly adjusted after opening low, then went up again. By the end of the afternoon session, it had a rise or fall.
The Metaverse Concept Index, which was just adjusted yesterday, once again jumped high today. The intraday volume bucked the trend and surged by more than 4%, reaching a record high. Half-day transactions surpassed yesterday's full-day transactions. Chinese Online and Liyuan Information went up and down 20%, while Phillips, Changxin Technology, etc. rose or dropped by more than 10%.
The hype about the metaverse concept is not only unaffected by regulation; on the contrary, there are signs of spread. Today, in response to an investor's question about “whether the company holds Uki shares in the social metaverse that targets Facebook,” Yongji Co., Ltd. replied on the Interactive Easy platform that currently the company's investment fund Jianzheng Yongji holds 6.8% of the shares in Shanghai Niuka Information Technology Co., Ltd. The company will promptly fulfill its credit disclosure obligations in accordance with relevant regulations in accordance with subsequent progress. Yongji shares had a sharp rise in early trading from near flat in just a few minutes.
Pingzhi Information announced today that in order to promote cooperation in VR related fields and promote the development of the VR industry, the company signed a “Strategic Cooperation Framework Agreement” with China Mobile (Jiangxi) Virtual Reality Technology Co., Ltd. and Dafeng Robotics Co., Ltd. on November 9, 2021 based on the principles of complementary advantages, equality and mutual benefit, and long-term cooperation, with the aim of jointly reaching strategic cooperation in the fields of VR/AR, robotic metaverse, artificial intelligence, and digital twins. The Pingji information rose and stopped a second after opening sharply higher in early trading. The transactions in the first minute of opening were higher than yesterday's full-day transactions.
Translated
3
$Pfizer (PFE.US)$ buy buy buy, going to the moon
16
$Pfizer (PFE.US)$ Pfizer pill for covid is available, 89% risk reduce for death and hospitalization, the share price will double. much better than MRK's 50%. buy buy buy
6
3
$Pfizer (PFE.US)$ Pfizer's specific medicine came out. If you go on a trip later, you only need to carry two boxes of Pfizer COVID medicine in your pocket. Once infected, take them out and take them for five days and recover immediately...
I told you to buy Pfizer a long time ago; you just didn't listen; now it's going to double... BUY BUY BUY...
I told you to buy Pfizer a long time ago; you just didn't listen; now it's going to double... BUY BUY BUY...
Translated
5
2
$Pfizer (PFE.US)$ The Moderna vaccine is not competitive enough, and the quality is unstable. Pfizer is seizing the market. Just look at the vaccinations received by the heads of state. All presidents have been vaccinated with the Pfizer vaccine, buy buy
Translated
3
1
$Futu Holdings Ltd (FUTU.US)$ I told you guys to buy days ago at the most trough. you have made tons of money if follow my suggestions, congratulations😄
6
3
$Pfizer (PFE.US)$ Raises Full-Year 2021 Guidance(4) for Revenues to a Range of $81.0 to $82.0 Billion and Adjusted Diluted EPS(3) to a Range of $4.13 to $4.18, Reflecting 94% and 84% Year-Over-Year Growth at the Midpoints, Respectively
PE ratio is 9%, buy buy buy ..... .....
PE ratio is 9%, buy buy buy ..... .....
3
$Pfizer (PFE.US)$ Pfizer's pill will be approved soon, buy...
The mid-to-late-stage study will test Pfizer's drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection.
In the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered along with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.
The mid-to-late-stage study will test Pfizer's drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection.
In the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered along with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.
6